Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy

BACKGROUND: Esophageal cancer patients face a dismal outcome despite tri-modality management and median survival remains 15-18 months. Breast cancer resistance protein (BCRP) is an ATP-dependent efflux protein associated with chemotherapy resistance. The role of BCRP expression in esophageal cancer...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bharthuar, Anubha, Saif Ur Rehman, Sana, Black, Jennifer D., Levea, Charles, Malhotra, Usha, Mashtare, Terry L., Iyer, Renuka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110489/
https://ncbi.nlm.nih.gov/pubmed/25083297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak